Francija opozarja na pomanjkljive kondome

France has issued a public warning over the recall of nearly 260,000 substandard condoms, which could pose serious health risks to users. The country’s anti-fraud and health agencies announced the recall on Friday, citing laboratory findings that revealed defects in some of the products. These included a risk of bursting and, in one instance, the presence of perforations. The affected condoms were found to lack essential safety certifications, including the CE marking, which signifies compliance with European Economic Area standards. The majority of the recalled condoms were sold online through major marketplaces by Asian vendors. According to the government agencies, approximately 1,000 boxes, equivalent to 40,000 individual condoms, had already been sold before the recall was announced. The products in question include two brands manufactured by Japan’s Okamoto Industries and two other brands, MyLubie and Friday Bae, produced by Passage du Desir. The agencies emphasized that these items failed to meet basic safety requirements, including proper packaging in French and third-party conformity assessments. French officials stated that the online vendors had agreed to remove the affected listings and return the recalled products. They also urged consumers who had used the condoms to undergo testing for sexually transmitted infections and to take a pregnancy test if they suspected possible exposure. This advice follows concerns that the faulty condoms could contribute to unintended pregnancies or increase the risk of contracting sexually transmitted diseases. The recall comes amid ongoing efforts by the French government to promote sexual health and prevent unplanned pregnancies. In France, individuals aged up to 25 can access free condoms through pharmacies without a prescription, a policy introduced during President Emmanuel Macron’s administration. This initiative aims to reduce rates of sexually transmitted infections and ensure broader access to contraception. In addition to online sales, the authorities conducted inspections in physical stores and discovered further instances of non-compliance. The findings highlight the need for stricter oversight of contraceptive products available both online and in retail environments. The total number of condoms sold in France in 2024 reached 115 million, underscoring the critical role these products play in public health. The issue has sparked discussions among consumer protection groups and healthcare professionals, who stress the importance of ensuring all contraceptive products meet rigorous safety standards. While the exact number of affected units varies slightly between reports, the consensus is clear: a large volume of condoms distributed through multiple channels have raised alarm due to potential safety hazards. As investigations continue, the focus remains on safeguarding public health and reinforcing regulatory measures to prevent similar incidents in the future.